Hubei Biocause Heilen Pharmaceutical Co., Ltd. (SHE:301211)
China · Delayed Price · Currency is CNY 9.34
-0.17 (-1.79%)
Jun 11, 2026, 1:15 PM CST
-27.97% (1Y)
| Market Cap | 3.97B -15.5% |
| Revenue (ttm) | 459.02M +8.7% |
| Net Income | 33.80M -47.6% |
| EPS | 0.08 -45.3% |
| Shares Out | 417.60M |
| PE Ratio | 118.88 |
| Forward PE | n/a |
| Dividend | 0.06 (0.63%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 1,694,763 |
| Open | 9.36 |
| Previous Close | 9.51 |
| Day's Range | 9.24 - 9.69 |
| 52-Week Range | 9.26 - 16.95 |
| Beta | 0.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 31, 2026 |